Does dexmedetomidine prevent emergence delirium in children after sevoflurane-based general anesthesia?

Area of Science:

• Pediatric Anesthesiology
• Pharmacology
• Critical Care Medicine

Background:

• Emergence agitation or delirium (ED) is common in children post-general anesthesia (GA).
• Dexmedetomidine, an alpha2 receptor agonist, possesses sedative and analgesic properties.
• The study investigated dexmedetomidine's efficacy in preventing ED in pediatric patients.

Purpose of the Study:

• To evaluate the effect of a continuous perioperative dexmedetomidine infusion on the incidence of emergence agitation or delirium (ED) in children.
• To assess if dexmedetomidine impacts recovery times, such as extubation and discharge from the post-anesthesia care unit (PACU).

Main Methods:

• A randomized controlled trial involving 50 children aged 1-10 years undergoing sevoflurane-based GA.
• Children received either dexmedetomidine (0.2 microg.kg(-1).h(-1)) or a placebo infusion perioperatively.
• Anesthesia depth was monitored using Bispectral Index Score (40-60), and ED was assessed by a blinded observer.

Main Results:

• The incidence of ED was significantly lower in the dexmedetomidine group (26%) compared to the placebo group (60.8%) (P = 0.036).
• The frequency of ED episodes was also significantly reduced with dexmedetomidine administration (P < 0.017).
• No significant differences were observed in pain scores or time to extubate and PACU discharge between groups.

Conclusions:

• Perioperative dexmedetomidine infusion effectively decreases the incidence and frequency of emergence agitation or delirium in children following sevoflurane-based GA.
• This therapeutic approach does not prolong tracheal extubation or post-anesthesia care unit discharge times.
• Dexmedetomidine represents a promising strategy for managing ED in pediatric anesthesia.